Literature DB >> 24362518

Manganese(III) porphyrins complexed with P22 virus-like particles as T1-enhanced contrast agents for magnetic resonance imaging.

Shefah Qazi1, Masaki Uchida, Robert Usselman, Riley Shearer, Ethan Edwards, Trevor Douglas.   

Abstract

Virus-like particles are powerful platforms for the development of functional hybrid materials. Here, we have grown a cross-linked polymer (cross-linked aminoethyl methacrylate) within the confines of the bacteriophage P22 capsid (P22-xAEMA) and functionalized the polymer with various loadings of paramagnetic manganese(III) protoporphyrin IX (MnPP) complexes for evaluation as a macromolecular magnetic resonance imaging contrast agent. The resulting construct (P22-xAEMA-MnPP) has r1,particle = 7,098 mM(-1) s(-1) at 298 K and 2.1 T (90 MHz) for a loading of 3,646 MnPP molecules per capsid. The Solomon-Bloembergen-Morgan theory for paramagnetic relaxivity predicts conjugating MnPP to P22, a supramolecular structure, would result in an enhancement in ionic relaxivity; however, all loadings experienced low ionic relaxivities, r 1,ionic, ranging from 1.45 to 3.66 mM(-1) s(-1), similar to the ionic relaxivity of free MnPP. We hypothesize that intermolecular interactions between neighboring MnPP molecules block access of water to the metal site, resulting in low r 1,ionic relaxivities. We investigated the effect of MnPP interactions on relaxivity further by either blocking or exposing water binding sites on MnPP. On the basis of these results, future design strategies for enhanced r 1,ionic relaxivity are suggested. The measured r 2,ionic relaxivities demonstrated an inverse relationship between loading and relaxivity. This results in a loading-dependent r 2/r 1 behavior of these materials indicating synthetic control over the relaxivity properties, making them interesting alternatives to current magnetic resonance imaging contrast agents.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24362518      PMCID: PMC4115648          DOI: 10.1007/s00775-013-1075-4

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  38 in total

1.  Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin. Optical and NMR spectroscopy characterization.

Authors:  Gabriella Fanali; Riccardo Fesce; Cristina Agrati; Paolo Ascenzi; Mauro Fasano
Journal:  FEBS J       Date:  2005-09       Impact factor: 5.542

2.  NMR paramagnetic relaxation of the spin 2 complex Mn(III)TSPP: a unique mechanism.

Authors:  Nathaniel Schaefle; Robert Sharp
Journal:  J Phys Chem A       Date:  2005-04-21       Impact factor: 2.781

Review 3.  Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Authors:  Peter Caravan
Journal:  Chem Soc Rev       Date:  2006-05-03       Impact factor: 54.564

4.  Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies.

Authors:  Jacob M Hooker; Ankona Datta; Mauro Botta; Kenneth N Raymond; Matthew B Francis
Journal:  Nano Lett       Date:  2007-07-14       Impact factor: 11.189

5.  Paramagnetic metalloporphyrins as potential contrast agents in NMR imaging.

Authors:  C W Chen; J S Cohen; C E Myers; M Sohn
Journal:  FEBS Lett       Date:  1984-03-12       Impact factor: 4.124

Review 6.  Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.

Authors:  Willem J M Mulder; Gustav J Strijkers; Geralda A F van Tilborg; Arjan W Griffioen; Klaas Nicolay
Journal:  NMR Biomed       Date:  2006-02       Impact factor: 4.044

7.  Dynamic relaxometry: application to iron uptake by ferritin.

Authors:  V Herynek; J W Bulte; T Douglas; R A Brooks
Journal:  J Biol Inorg Chem       Date:  2000-02       Impact factor: 3.358

Review 8.  Paramagnetic liposome nanoparticles for cellular and tumour imaging.

Authors:  Nazila Kamaly; Andrew D Miller
Journal:  Int J Mol Sci       Date:  2010-04-15       Impact factor: 5.923

9.  Viral capsids as MRI contrast agents.

Authors:  Lars Liepold; Stasia Anderson; Deborah Willits; Luke Oltrogge; Joseph A Frank; Trevor Douglas; Mark Young
Journal:  Magn Reson Med       Date:  2007-11       Impact factor: 4.668

10.  Porphyrin-substituted H-NOX proteins as high-relaxivity MRI contrast agents.

Authors:  Michael B Winter; Piper J Klemm; Christine M Phillips-Piro; Kenneth N Raymond; Michael A Marletta
Journal:  Inorg Chem       Date:  2013-02-08       Impact factor: 5.165

View more
  10 in total

Review 1.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

2.  Contrast agents for MRI: 30+ years and where are we going?

Authors:  Valérie C Pierre; Matthew J Allen; Peter Caravan
Journal:  J Biol Inorg Chem       Date:  2014-01-11       Impact factor: 3.358

Review 3.  Bacteriophage lambda: Early pioneer and still relevant.

Authors:  Sherwood R Casjens; Roger W Hendrix
Journal:  Virology       Date:  2015-03-03       Impact factor: 3.616

Review 4.  Development of virus-like particles for diagnostic and prophylactic biomedical applications.

Authors:  Benjamin Schwarz; Trevor Douglas
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-02-13

Review 5.  Virus-Based Nanoparticles as Versatile Nanomachines.

Authors:  Kristopher J Koudelka; Andrzej S Pitek; Marianne Manchester; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2015-09-25       Impact factor: 10.431

6.  Gadolinium-Loaded Viral Capsids as Magnetic Resonance Imaging Contrast Agents.

Authors:  Robert J Usselman; Shefah Qazi; Priyanka Aggarwal; Sandra S Eaton; Gareth R Eaton; Stephen Russek; Trevor Douglas
Journal:  Appl Magn Reson       Date:  2015-01-11       Impact factor: 0.831

Review 7.  Plant Viruses and Bacteriophage-Based Reagents for Diagnosis and Therapy.

Authors:  Sourabh Shukla; He Hu; Hui Cai; Soo-Khim Chan; Christine E Boone; Veronique Beiss; Paul L Chariou; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2020-09-29       Impact factor: 10.431

Review 8.  Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications.

Authors:  Young Hun Chung; Hui Cai; Nicole F Steinmetz
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

Review 9.  Recent progress in targeted delivery vectors based on biomimetic nanoparticles.

Authors:  Li Chen; Weiqi Hong; Wenyan Ren; Ting Xu; Zhiyong Qian; Zhiyao He
Journal:  Signal Transduct Target Ther       Date:  2021-06-07

Review 10.  Recent Advances in Photosensitizers as Multifunctional Theranostic Agents for Imaging-Guided Photodynamic Therapy of Cancer.

Authors:  Paromita Sarbadhikary; Blassan P George; Heidi Abrahamse
Journal:  Theranostics       Date:  2021-08-26       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.